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Electroacupuncture Provides a New Approach to Neuroprotection
in Rats with Induced Glaucoma
HENRY H.L. CHAN, Ph.D.,1 MASON C.P. LEUNG, Ph.D.,2 and KWOK-FAI SO, Ph.D.3
ABSTRACT
Objectives: To investigate, using multifocal electroretinogram (mfERG), the effect of electroacupuncture
(EA) on retinal function in rats with experimental glaucoma.
Design and subjects: Glaucoma was induced in the right eyes of 15 adult female Sprague-Dawley rats by
laser photocoagulation for three quarters of the perilimbal and episcleral vessels. The left eye of each rat was
used as the control. The animals were divided into 3 groups: no treatment (non-EA control group), 2 Hz EA
group, and 100 Hz EA group. EA treatment at different frequencies can produce different levels of analgesia
and hence the effect of EA with different frequencies on glaucoma treatment was investigated. Both eyes of
each rat in the EA experimental groups received 3 EA treatment sessions each week for 4 weeks. The retinal
function was measured using mfERG after 4 weeks of EA treatment.
Results: There was no significant difference in the amplitude (both N1 trough and P1 peak) of mfERG first-
order kernel response between the treatment and control groups. In determining the waveform characteristics
by the ratio of N1 amplitude to P1 amplitude (N/P ratio), obvious differences were found in the N/P ratio be-
tween the control eyes and the glaucoma eyes in the non-EA group and the 100 Hz EA treatment group, but
similar values in the N/P ratio were observed between the control eyes and the glaucoma eyes in the 2 Hz EA
treatment group. The waveform from the eyes with glaucoma was deformed in both the non-EA group and the
100 Hz EA group, but the waveform from the glaucomatous eye was preserved in the 2 Hz EA group.
Conclusions: Application of EA at 2 Hz provides neuroprotection by preserving retinal function in rats with
experimental glaucoma. Low frequency EA may be an alternative therapy in the treatment of glaucoma.
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INTRODUCTION
Glaucoma is the second leading cause of blindness world-wide. It is characterized by optic neuropathy with pro-
gressive loss of retinal ganglion cells (RGCs) causing exca-
vation of the optic disc and finally visual field loss (Nickells,
1996; Quigley et al., 1981). There are at least two theories
of glaucoma: The mechanical theory suggests that the dam-
age is a result of compression of the axons from elevated in-
traocular pressure (IOP) at the optic nerve head, while the
vascular theory suggests that high IOP induces ischemia by
limiting the blood supply to the retina (Anderson, 1987).
While mechanical compression and ischemia may be the
initial insults (Schwartz et al., 1996), other primary de-
structive factors have also been suggested for the apoptosis
of RGCs (Garcia-Valenzuela et al., 1995; Kerrigan et al.,
1997; Quigley et al., 1995), such as the short-term release
of glutamate (Dreyer et al., 1996) or nitric oxide (NO) (Mor-
gan et al., 1999; Siu et al., 2002), and a shortage of neu-
rotrophic factors.
One of the isoforms of nitric oxide synthase, nitric oxide
synthase-2 (NOS-2), also known as induced nitric oxide syn-
thase (iNOS), seems to play an important role in glauco-
matous damage (Becquet et al., 1997; Neufeld et al., 1999;
Siu et al., 2002). NOS-2 is transiently induced after expo-
sure to cytokines or endotoxins and produces a large quan-
tity of NO, which combines with superoxide to form a per-
oxynitrite anion. The peroxynitrite anion then decomposes
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to form toxic hydroxyl free radical (OH) (Lipton et al.,
1993) and triggers apoptosis (Garcia-Valenzuela et al., 1995;
Kerrigan et al., 1997; Quigley et al., 1995). This new hy-
pothesis of glaucomatous etiology has led to several studies
exploring new treatment by inhibiting NOS-2.
Aminoguanidine, an NO inhibitor, has been used by
Neufeld and colleagues (1999) to investigate neuroprotection
in glaucoma. Their results indicate that the axons at the op-
tic nerve head of rats with glaucoma were protected after ad-
ministration of the NO inhibitor. The study showed that re-
duction of NOS-2 can help to lessen glaucomatous damage.
Acupuncture is a branch of Traditional Chinese Medicine
(TCM) which has been used for more than 2000 years in
the treatment of various diseases (Lin, 1991; Shao and Ding,
1985; Song, 1993; Stux and Pomeranz, 1988). Recent stud-
ies suggest that acupuncture causes inhibition of NOS (Le-
ung et al., 2000; Yang et al., 2000). Leung and colleagues
(2000) have shown that the total functional activity of NOS
decreased significantly in glaucomatous rat eyes after EA
treatment. Dabov and colleagues (1985) reported significant
decreases in the IOP of glaucoma patients after acupuncture
treatment. These studies support the idea that acupuncture
could produce neuroprotective effects in glaucoma. How-
ever, no study has been done to measure the retinal func-
tion when acupuncture is used as a treatment for glaucoma.
In this study, a rat glaucoma model was used to investi-
gate the effects of acupuncture. Experimentally induced glau-
coma in the rat has proven to be a useful protocol for glau-
coma studies (Siu et al., 2002). The VERIS multifocal
electroretinogram (mfERG) system (EDI, San Francisco, CA)
was used to provide objective measurement of the glauco-
matous changes and retinal function of the animals. Multiple
retinal areas were stimulated simultaneously, and responses
from different regions of the retina were examined to give a
clear indication of central and pericentral electrical responses.
Previous studies have used mfERG to measure glaucomatous
changes (Chan and Brown, 1999; Chan and Brown, 2000).
These findings have suggested that the mfERG system is an
effective and reliable tool for measuring retinal changes in
pathological conditions. The present study also investigated
the effects of 2 frequencies of EA stimulation on glaucoma
treatment, as some previous studies had reported that EA at
different frequencies produced different levels of analgesia
(Han et al., 1999; Huang et al., 2000).
MATERIALS AND METHODS
Animal preparation
Fifteen (15) adult female Sprague-Dawley rats weighing
200–300 g were used. The animals were kept in a tempera-
ture-controlled (24°C) room subjected to a 12 hour light/12
hour dark cycle and were provided with adequate food and
water. They were handled in strict accordance with the regu-
lations of the animal ethics subcommittee of The Hong Kong
Polytechnic University. Glaucoma was induced in the right
eye by laser irradiation to three-quarters of the perilimbal re-
gion using standard laser equipment (Ultima® 2000 SE Ar-
gon Laser; Coherent, Ontario, Canada). This technique of laser
photocoagulation has been proposed in previous studies (Ji et
al., 2004; Levkovitch-Verbin et al., 2002; Schori et al., 2001;
Siu et al, 2002; WoldeMussie et al., 1997; WoldeMussie et
al., 2001). Briefly, the laser photocoagulation of the episcle-
ral and limbal drainage vessels in a 270 degree arc around the
perilimbal region (excluding the nasal quadrant) produces suf-
ficient outflow blockages. The left eye was not manipulated
in any way and was used as control. Laser photocoagulation
was done twice, 7 days apart. Our lab has shown that this laser
photocoagulation technique induces significant IOP elevation,
ganglion cell death, and glaucomatous damage in rats (Siu et
al., 2002). The rats were anesthetized for IOP measurement
of each eye by TonoPen (Xomed, Jacksonville, FL). Three
sets of readings were recorded to obtain a mean value. The
IOP of the rats in each group were measured at the first week
and the last week of EA treatment (Table 1).
The rats were divided into 3 groups: 5 rats were used as
controls without any EA treatment (non-EA group), 5 rats
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TABLE 1. INTRAOCULAR PRESSURE (MEAN AND STANDARD ERROR OF THE MEAN IN
GLAUCOMATOUS AND CONTROL EYES IN 3 GROUPS (A, B, AND C)
(A) Non-EA (B) 2-Hz EA (C) 100-Hz EA
Conducted after EA treatment n  4 n  5 n  5
First week of EA treatment
Glaucomatous (right) eye 28.25  4.35 mmHg* 20.83  5.38 mmHg 19.33  3.56 mmHg**
Control (left) eye 23.33  6.11 mmHg* 20.83  2.79 mmHg 24.0  3.35 mmHg**
Last week of EA treatment
Glaucomatous (right) eye 26.75  2.75 mmHg* 19.67  3.33 mmHg 20.0  1.41 mmHg**
Control (left) eye 17.50  3.70 mmHg* 18.33  2.42 mmHg 18.5  1.05 mmHg**
Note: The intraocular (IOP) pressures in glaucomatous eyes in the nonelectroacupuncture group (*p  0.05) and in the 100-Hz EA
group **p  0.01) were higher than those in the control eyes. The reduction of elevated IOP occurred in glaucomatous eyes after 4
weeks of 2-Hz EA treatment (p  0.05).
EA, electroacupuncture.
underwent EA treatment at 2 Hz (2 Hz EA group), and 5
rats underwent EA at 100 Hz (100 Hz EA group). The EA
treatments were started 1 week after the second laser pho-
tocoagulation.
EA treatment
Both treatment groups received EA treatment on days 1,
3, and 5 each week for 4 weeks. Prior to each EA treatment,
the animal received general anesthesia with an intraperitoneal
injection of ketamine 10% (0.2 mL per 300 g body weight)
(Alfamedic) and xylazine 2% (0.1 mL per 300 g body weight)
(Alfamedic) and, if necessary, a supplemental dose was given
after approximately 45 minutes. The rat was then placed on
a plastic board and the body covered with a cloth to keep it
warm during the EA treatment. Sterile disposable acupunc-
ture needles were inserted bilaterally at acupoints A and B,
which correspond to the acupoints HN4 (Extra Point Yuyao)
and ST1 (Chengqi) in the human (Fig. 1). The electrical stim-
ulus was generated by an electrostimulator (ITO IC-4107,
Japan) with an electrical current of approximately 1 mA for
both 2 Hz and 100 Hz EA groups. Each EA treatment lasted
20 minutes and both eyes (control eye and glaucoma eye) re-
ceived the treatment simultaneously.
mfERG recording
The mfERG system generated visual stimuli to multiple
retinal areas and measured the retinal responses of each of
these areas. It analyzed the retinal responses using kernel
analysis to assess nonlinear function of the retina (Chan and
Brown, 1999; Chan and Brown, 2000). The mfERG record-
ing was performed after 4 weeks of EA treatment. The an-
imal was dark-adapted overnight and anesthetized. Each
pupil was dilated with a drop of 1% tropicamide (Alcon)
and the corneal surface was locally anesthetized with a drop
of 0.4% novesin (Alcon). A silver electrode was placed onto
the corneal surface and referenced to a surface electrode on
the ipsilateral ear. The ground electrode was placed on the
contralateral ear. The preparation and measurement were
done in dim red light.
The animal was anesthetized with the same procedure as
for the EA treatment, and placed on a movable plastic plat-
form at a height of 16 cm and positioned 50 cm from the
mfERG stimulus monitor (15-inch Apple RGB monitor).
The platform was adjusted so that the line of sight of the rat
was aligned with the center of the mfERG stimulus pattern
displayed on the monitor. No optical correction was used
because the depth of focus for rats is approximately 10
diopters and generally they are emmetropic (Remtulla and
Hallett, 1985). After the mfERG recording, the animal was
allowed to recover from anesthesia before it was returned
to its cage.
Stimulus for multifocal ERG measurement
A 61-hexagon nonscaled stimulus array was used for
the multifocal ERG measurement in this study. The visual
stimulus was generated by the Visual Evoked Response
Imaging System (VERIS 1.0; EDI, San Francisco) on the
stimulus monitor. The stimulus pattern was about 24 cm
horizontal and 17 cm vertical, giving an angular subtend
of 26 degrees  20 degrees. A neutral density filter (1.0)
and a Kodak W47A blue filter (max  470 nm, band-
width  20 nm) were positioned 1 cm in front of the tested
eye. The stimulus luminance was measured using a Top-
con BM-5 Luminance Meter with a 0.2 degree field. The
luminance of the stimuli, after passing through the two fil-
ters, was 0.005 cd/m2 for the black hexagon and 1.38
cd/m2 for the white hexagon (mean luminance  0.69
cd/m2, 99% contrast).
As rats are nocturnal animals, dark blank frames between
the stimulus frames were introduced for the recovery of the
rod system. Nusinowitz and colleagues (1999) used 14 dark
blank frames in between the flashes for the mfERG mea-
surement (the interval is about 14  13.33 msec  186.6
msec) in rats. Since the frame rate (60 Hz) in this study was
slower than the one used in their study, the number of in-
serted blank frames between flashes was 12 and the inter-
val was about 200 msec (12  16.67 msec). This ensured
sufficient time for recovery of the rod system. The selected
m-sequence was 212-1 and required about 14 minutes to
complete one recording. Each recording was done in two
segments to allow for rechecking of the status and posi-
tioning of the animal. Therefore, the total duration for
mfERG recording for both eyes was about 30 minutes.
Data analy\sis
The first-order kernel mfERG response was extracted
and averaged to show the variation of the retinal functions
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FIG. 1. Needles were inserted in acupoints A and B, which cor-
respond to acupoints HN4 and ST01 in humans (upper left corner).
Electrical stimulation was provided by acupunctoscope and the cur-
rent was fixed at 1mA.
in different groups. The response of two components (N1
trough and P1 peak) was measured in the experiment (Fig.
2). Apart from the magnitudes of N1 and P1, the ratio of
N1 to P1 (N/P ratio) was calculated to demonstrate the vari-
ation of waveform characteristics. Student’s paired t-test
was chosen as the statistical method of data analysis be-
tween the eyes in each treatment group, and the multiple t-
test was chosen to analyze the treatment effect between dif-
ferent groups. The alpha level was 0.05 for the statistical
analysis.
RESULTS
The first-order kernel responses in mfERG of the animals
were measured. One rat was excluded from the control group
during the first week due to unexpected hypersensitivity 
to the anesthetic, leaving a total of 14 rats for the mfERG
study after 4 weeks of EA treatment. A typical summed 61
mfERG response waveform recorded from the left eye (con-
trol eye) of a rat from the control (non-EA) group is shown
in Figure 3A. This clearly demonstrates that the control eye
has similar waveforms across the retina. Another typical
summed 61 mfERG response recorded from the glaucoma-
tous right eye of the same rat is shown in Figure 3B. Changes
in the waveforms are seen across the retina, which might re-
flect functional change following the induced glaucomatous
damage.
mfERG response amplitude
In the non-EA group, relatively large abnormal mfERG
responses (both N1 and P1) were recorded from the glau-
comatous eye (Fig. 4). The N1 and P1 responses from both
the glaucomatous (right) and control (left) eyes in the 2 Hz
and 100 Hz EA groups were similar. There was no statisti-
cally significant difference in the N1 and P1 responses be-
tween the two eyes in the control group (N1, t  1.85, p 
0.05; P1, t  1.02, p  0.05) or in either EA treatment
groups (2 Hz EA treatment: N1, t  0.54, p  0.05; P1,
t  0.31, p  0.05; 100 Hz EA treatment: N1, t  0.30,
p  0.05; P1, t  0.62, p  0.05). In addition, in the com-
parison of the N1 and P1 responses of the glaucomatous and
control eyes, there were no differences among all three
groups (N1 response in glaucomatous eye: non-EA versus
2 Hz EA, t  1.77, p  0.05; non-EA versus 100 Hz EA,
t  1.28, p  0.05; P1 response in glaucomatous eye: non-
EA versus 2 Hz EA, t  0.76, p  0.05; non-EA versus 100
Hz EA, t  0.92, p  0.05; N1 response in control eye: non-
EA versus 2 Hz EA, t  0.65, p  0.05; non-EA versus
100 Hz EA, t  0.76, p  0.05; P1 response in control
eye: non-EA versus 2 Hz EA, t  0.18, p  0.05; non-EA
versus 100 Hz EA, t  0.73, p  0.05). The glaucoma-
tous eyes without any EA treatment had abnormal increases
in N1 and P1 amplitude as compared to the control eyes al-
though the comparison is not statistical significant. This il-
lustrated that the glaucomatous damage causes the func-
tional changes in the retina. For both EA treatment groups,
the glaucomatous eyes did not show any abnormal increase
in amplitude as compared to the control eyes, demonstrat-
ing the tentative effect of EA on glaucoma treatment. There-
fore, we plan to change our future study design to investi-
gate the effect of EA on glaucoma treatment.
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FIG. 2. The multifocal electroretinogram response from the left
eye of a rat from the non-electroacupuncture (EA) group. Ampli-
tudes of N1 and P1 were measured from the baseline to the peak
of N1 and the amplitude of P1 was measured from N1 to peak of
P1.
FIG. 3. Multifocal electroretinogram of the non-electroacupunc-
ture (EA) treatment groups from the (A) left control eye and (B)
the right glaucomatous eye of a rat in the non EA treatment group.
The peaks of P1 were attenuated in the glaucomatous eye com-
pared to those seen in the control eye. This illustrates that glauco-
matous damage can affect the waveform characteristics.
A
B
mfERG response ratio (N/P ratio)
Change of waveform characteristics is an important sign
of glaucomatous damage in mfERG response. The N/P ra-
tio from this study was analyzed to estimate retinal func-
tion. The N1 and P1 responses have opposite polarities and
they influence each other in a manner similar to the a-wave
and b-wave in flash ERG. In a normal flash ERG waveform
under fixed measuring conditions (following ISCEV guide-
lines), the waveform characteristic is related to the a-wave
to b-wave amplitude ratio. An abnormal ratio of a-wave to
b-wave reflects abnormality in the retinal function. We pos-
tulate that the same concept is also true for the mfERG wave-
form.
Thus, N/P ratio waveform changes are analyzed to ex-
trapolate the retinal function under different EA treatment
conditions. In the treatment groups, the N/P ratios from all
the control eyes showed similar values, but relatively larger
differences were found in the glaucomatous eyes (Fig. 5).
In the non-EA control group, the N/P ratio of the glauco-
matous eyes was significantly higher than that of the control
eyes (t  5.81, p  0.01). In the 2 Hz EA group, the mean
N/P ratio and standard deviation (SD) of the glaucomatous
eyes were similar to that of the control eyes and there was no
significant difference between them (t  0.26, p  0.05).
In the 100 Hz EA group, the mean N/P ratio of the glauco-
matous eyes was higher than that of the control eyes. How-
ever, the difference was not significant due to the large SD
of the ratios in the glaucomatous eyes (t  0.87, p  0.05).
In the comparison of the N/P ratio of glaucomatous eyes
between the non-EA and 2 Hz EA groups, there was a statis-
tically significant difference (t  2.18, p  0.05), but not be-
tween the non-EA and 100 Hz EA groups (t  0.19, p  0.05).
This demonstrated that 2 Hz EA treatment can influence the
N/P ratio of the glaucoma eye, but not the 100 Hz EA treat-
ment. In the comparison of the N/P ratio of control eyes among
all three groups, there was no difference (non-EA versus 2 Hz
EA, t  0.85, p  0.05; non-EA versus 100 Hz EA: t 
0.26, p  0.05), that is, the EA treatment had no effect on
the control eyes. The results show that the 2 Hz EA treatment
can maintain the N/P ratio (ERG waveform characteristics) of
the glaucomatous eye similar to that of the normal eye.
DISCUSSION
Previous studies have suggested that glaucomatous
damage is a result of nitric oxide (NO) toxicity (Fisher et
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FIG. 5. N/P Ratios of the induced-glaucomatous and control
eyes. In the non-electroacupuncture (EA) group, there was a large
difference (about 50%) between the control eyes and the glauco-
matous eyes (#p  0.01). This illustrates that the glaucomatous
eyes had significant changes in the N/P ratio. For the 2-Hz and
100-Hz EA groups, it was clearly illustrated that the 2-Hz EA group
maintained the N/P ratio in glaucoma eyes (p  0.05) but the 100-
Hz EA group (p  0.05) did not. In the comparison of the N/P ra-
tio of glaucomatous eyes between the non-EA and 2 Hz EA groups,
the difference was statistically significant (*p  0.05), but this was
not the case between the non-EA and the 100-Hz EA groups (p 
0.05). In the comparison of the N/P ratio of control eyes, there
were no statistically differences among all three treatment and con-
trol groups (p  0.05).
FIG. 4. Amplitudes (mean and SEM) of A. N1 and B. P1 in in-
duced-glaucoma and control eyes. In the non-electroacupuncture
(EA) group, there were large differences (50 to 64%) in both 
N1 and P1 responses between the control eyes and the glauco-
matous eyes. For the 2 Hz and 100 Hz EA groups, there was less
difference (10 to 20%) in the N1 and P1 responses between the
control eyes and the glaucomatous eyes. These suggest that the
retinal function of glaucoma eyes may have been preserved in
both EA treatments. However, the high variances of the results




al., 2001; Morgan et al., 1999; Neufeld et al., 1999; Siu
et al., 2002). Our group, using a similar rat glaucoma
model, has found that acupuncture treatment could inhibit
the expression of NOS-2 (Leung et al., 2000). In a recent
study, we used acupuncture points based on the “local
point” principal in another animal model (Siu et al., 2004),
and found them effective. In the present study, using the
same acupuncture points, we show that EA is effective in
maintaining retinal function (i.e., mfERG) in the glau-
coma rat model. Although the mfERG was not measured
before the EA treatments, the control eyes were used for
comparing the results, and the selection of glaucoma-in-
duced rats for each treatment group was random to en-
sure that there was no bias to the different EA treatment
conditions.
Laquis and colleagues (1988) reported that the percent-
age of RGC death was about 4% per week after induced
IOP elevation whereas our laboratory has found that RGC
death reached about 30% after 5 weeks of IOP elevation
(Siu et al., 2002). Therefore, the estimated RGC loss would
be 20–30% after 5 weeks of IOP elevation. Mittag and co-
workers (2000) used the scotopic full-field ERG to inves-
tigate functional retinal changes in a glaucoma rat model
and found that the decline in amplitude in the ERG re-
sponses of the glaucomatous eyes was not significant un-
til after 15 weeks of elevated IOP. This illustrates that the
amount of dead/damaged RGCs at 5 weeks of IOP eleva-
tion may not be high enough to express reductions in
mfERG response.
The present study shows that there is only a moderate
difference in the absolute mfERG amplitudes of N1 and
P1 between the glaucomatous and control eyes in both
treatment groups. Some studies have reported changes of
waveform characteristics as a sign of glaucomatous dam-
age in human mfERG response, even in the absence of
any significant reduction in the response amplitude
(Bearse et al., 1996; Hasegawa et al., 2000; Hood et al.,
1999; 2002). Thus, the N/P ratio in waveform changes
may be useful in the interpretation of the retinal function
under different EA treatment conditions since the nega-
tive trough (N) and the positive peak (P) in the mfERG
are related to the activities of off-bipolar and on-bipolar
cells respectively (Hood et al., 2002). The glaucomatous
damage may cause functional changes in these cells. Lau
et al. (1994) have found that NOS is mainly secreted from
the amacrine cells which are directly or indirectly con-
nected to the bipolar cells. This can explain why the N/P
ratio would reflect retinal function. The glaucomatous
eyes receiving 2 Hz EA treatment showed N/P ratios sim-
ilar to those of the control eyes. In a recent study, using
mfERG measurement on monkeys with experimentally in-
duced glaucoma and reared under low luminance or low
contrast conditions, the N/P ratio was increased in the
glaucomatous eyes (Raz et al., 2002). This supports the
hypothesis that the N/P ratio is a possible indicator for
measuring glaucomatous damage. Leung and co-workers
(2000) have shown that the amount of NOS-2 is higher in
glaucomatous eyes but is reduced after receiving 2 Hz EA
treatment. In this study, the normal waveform character-
istics were maintained in the glaucomatous eyes receiv-
ing EA treatment, which may be attributed to the inhibi-
tion of NOS-2. It is interesting to note that the
neuroprotective effect of low frequency EA on the glau-
comatous eye in the present study was also found in a
cerebral ischemia model (Siu et al., 2004) On the other
hand, the glaucomatous eyes receiving 100 Hz EA treat-
ment did not show N/P ratio values similar to the control
eyes. This might indicate that 2 Hz EA is effective in pro-
tecting the retina from insults, while 100 Hz EA produces
little or no effect.
Comparing the effects of 2 Hz and 100 Hz EA treatments
on retinal function in this study, the 2 Hz EA treatment pre-
served mfERG waveform characteristics in terms of the N/P
ratio. Low and high stimulation frequencies of EA treatment
seem to have different effects on the nervous system. In pre-
vious studies on the analgesic effect of EA, the -endorphin
release in rats was stimulated by 2 Hz EA but was not 100
Hz EA (Han et al., 1999; Huang et al., 2000).
We speculate that different EA treatment frequencies trig-
ger different neuroprotective responses in the glaucomatous
eye. Further investigation on the effects of low and high EA
stimulation on NOS-2 in glaucoma is required.
CONCLUSIONS
This study demonstrates the neuroprotective effect of EA
on glaucoma in rats by measuring their retinal responses.
This study suggests that EA could be a potential treatment
in preventing glaucomatous damage in human, but further
investigation is necessary. Different EA stimulation fre-
quencies produce different effects and low stimulation fre-
quency (2 Hz) EA was preferable in treating glaucoma in
rats. EA could be a good alternative therapy and novel ap-
proach to dealing with obstinate neurodegenerative diseases
such as glaucoma. We hope that further research will be un-
dertaken to explore this approach.
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